213 related articles for article (PubMed ID: 1091283)
1. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
Johnson BF; Bye C
Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
[TBL] [Abstract][Full Text] [Related]
2. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
Manninen V; Reissell P; Ojala K
Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
[TBL] [Abstract][Full Text] [Related]
3. Absorption of digoxin from a new microencapsulated formulation.
Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
[TBL] [Abstract][Full Text] [Related]
4. A completely absorbed oral preparation of digoxin.
Johnson BF; Bye C; Jones G; Sabey GA
Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
[TBL] [Abstract][Full Text] [Related]
5. Absolute bioavailability of digoxin tablets.
Beveridge T; Nüesch E; Ohnhaus EE
Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of drugs: the digoxin dilemma.
Greenblatt DJ; Smith TW; Koch-Weser J
Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
Binnion PF
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
[TBL] [Abstract][Full Text] [Related]
8. Digoxin absorption from tablets and elixir. The effect of radiation-induced malabsorption.
Jusko WJ; Conti DR; Molson A; Kuritzky P; Giller J; Schultz R
JAMA; 1974 Dec; 230(11):1554-5. PubMed ID: 4479663
[No Abstract] [Full Text] [Related]
9. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
Boerner D; Olcay A; Schaumann W; Weiss W
Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
Bochner F; Huffman DH; Shen DD; Azarnoff DL
J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
[TBL] [Abstract][Full Text] [Related]
11. Intersubject variation in absorption of digoxin in normal volunteers.
Huffman DH; Manion CV; Azarnoff DL
J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
[TBL] [Abstract][Full Text] [Related]
12. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
Härtel G; Manninen V; Melin J; Apajalahti A
Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
[No Abstract] [Full Text] [Related]
13. Effect of a standard breakfast on digoxin absorption in normal subjects.
Johnson BF; O'Grady J; Sabey GA; Bye C
Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
[TBL] [Abstract][Full Text] [Related]
14. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
[TBL] [Abstract][Full Text] [Related]
15. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
Falch D; Teien A; Bjerkelund CJ
Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
[TBL] [Abstract][Full Text] [Related]
18. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
Ochs H; Bodem G; Hahn E; Dengler HJ
Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
[TBL] [Abstract][Full Text] [Related]
20. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
Johnson BF; Smith G; French J
Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
